
Anne Cassity, senior vice president of government affairs at NCPA, discusses the next moves of both PBMs and community pharmacy advocates following the signing of HR 7148.

Anne Cassity, senior vice president of government affairs at NCPA, discusses the next moves of both PBMs and community pharmacy advocates following the signing of HR 7148.

With President Trump’s signing of HR 7148, experts are now racing to get a grasp on the monumental shifts in pharmacy that will stem from this new legislation.

As lawmakers continue to deliberate on HR 7148, pharmacy law expert, Jesse Dresser, Esq, joined Drug Topics to discuss its provisions related to PBMs.

If signed by President Trump in time to avoid a government shutdown, HR 7148 has potential to enforce significant change in the prescription drug supply chain.

As more prescription drugs move to OTC, the pharmacist’s role in their communities are continuing to shift as well.

With unprecedented changes to Medicare Part D plans at the top of the year, experts from ASCP help pharmacy businesses understand key provisions under the IRA.

Representatives from the American Society of Consultant Pharmacists joined Drug Topics to discuss the day 1 reality of the Medicare Drug Price Negotiation Program.

To celebrate National Pharmacist Day, regonized every year on January 12, Meagan Brown, PharmD, BCACP, discussed the current state of nationally recognizing pharmacists as clinical providers.

Meagan Brown, PharmD, BCACP, discusses the nuances of pharmacists’ provider status and its evolution within the greater health care community.

Meagan Brown, PharmD, BCACP, discusses her career journey in various pharmacy roles during National Pharmacist Day, January 12.

From gaps in care to formulary challenges, Susan Thomas, RN, explains how her independent PBM is working with pharmacists to improve women’s health outcomes.

Susan Thomas, RN, joined Drug Topics to discuss current gaps in women’s health and how pharmacists are stepping in to counsel in this space more than ever before.

Pharmacists are transforming reproductive health care by expanding their roles in contraception and patient support, despite facing significant barriers.

As social media’s growth seemingly has no end in sight, pharmacists must be conscious of its potential risks and benefits when using these platforms for either personal or professional use.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Julissa Gomez, a fourth-year pharmacy student at the University of Illinois Chicago Retzky College of Pharmacy.

Pharmacists are expanding their roles in reproductive health, overcoming barriers to provide essential services and improve community care.

In part 3 of our interview with Kenric B. Ware, PharmD, MBA, AAHIVP, he discusses the best approaches for addressing HIV care and prevention stigma.

Kenric B. Ware, PharmD, MBA, AAHIVP, addresses the pharmacist’s role in addressing HIV stigma and providing public health services for patients with the virus.

Pharmacists play a crucial role in educating patients about birth control, improving access to care, and addressing maternal health challenges in Arkansas.

Arkansas pharmacists enhance women's health by implementing new protocols for oral contraceptive prescriptions, improving patient care and confidence.

Discover how pharmacy teams are advancing stewardship, opioid safety, and survey readiness through clinical surveillance, competency-based education, and emerging AI tools that help reduce ADEs and improve patient outcomes.

During his second term, President Trump has bolstered his approach at lowering prescription drug prices in the US through innovative yet unprecedented decisions.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed potential safety concerns and the pharmacist’s role in managing insulin.

Ron Lanton III, Esq, provides nuance to the current state of pharmacy sustainability and how the MFN drug pricing policy could impact the industry.

Ron Lanton III, Esq, discusses previous MFN drug pricing policies and why the free US drug market often yields higher patient costs.

Ron Lanton III, Esq, discusses the revamped version of the Trump Administration’s MFN drug pricing policy and why his second term may yield different outcomes.

McKesson’s Ginger Thorpe discusses the gaps and opportunities in specialty pharmacy’s approach toward care coordination within health systems.

Pharmacists navigate the evolving landscape of cannabis, balancing patient expectations with emerging evidence on cannabidiol and tetrahydrocannabinol for various medical conditions.

Explore the complexities of cannabinoids, focusing on cannabidiol and tetrahydrocannabinol, their effects, side effects, and potential drug interactions in modern use.

Megan Smith, PharmD, discusses how pharmacists have taken reigns in boosting pneumococcal vaccine rates across health care.